Raised serum level of APRIL in patients with systemic lupus erythematosus: Correlations with disease activity indices

Clinical Immunology

Volumn 135, Issue 1, 2010, Pages 118-124

  Hegazy, M ^a   Darwish, H ^a   Darweesh, H ^a   El Shehaby, A ^a   Emad, Y ^a  

^a CAIRO UNIVERSITY   (Egypt)

Author keywords

APRIL; Rheumatoid arthritis; ; Systemic lupus erythematosus;

Indexed keywords

APRIL PROTEIN;

ADULT; ARTICLE; CLINICAL ARTICLE; CONTROLLED STUDY; CORRELATION ANALYSIS; DISEASE ACTIVITY; FEMALE; HUMAN; MALE; MUSCULOSKELETAL DISEASE; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; SYMPTOM; SYSTEMIC LUPUS ERYTHEMATOSUS;

ADULT; ARTHRITIS, RHEUMATOID; CASE-CONTROL STUDIES; ENZYME-LINKED IMMUNOSORBENT ASSAY; FEMALE; HUMANS; LUPUS ERYTHEMATOSUS, SYSTEMIC; MALE; SEVERITY OF ILLNESS INDEX; STATISTICS, NONPARAMETRIC; TUMOR NECROSIS FACTOR LIGAND SUPERFAMILY MEMBER 13;

EID: 77649237175     PISSN: 15216616     EISSN: 15217035     Source Type: Journal    
DOI: 10.1016/j.clim.2009.12.012     Document Type: Article

References (43)

1. Kotzin B.L. Systemic lupus erythematosus. Cell 85 (1996) 303-306
2. Thompson J.S., Schneider P., Kalled S.L., Wang L., Lefevre E.A., Cachero T.G., MacKay F., Bixler S.A., Zafari M., Liu Z.Y., Woodcock S.A., Qian F., Batten M., Madry C., Richard Y., Benjamin C.D., Browning J.L., Tsapis A., Tschopp J., and Ambrose C. BAFF binds to the tumor necrosis factor receptor-like molecule B cell maturation antigen and is important for maintaining the peripheral B cell population. J. Exp. Med. 192 (2000) 129-135
3. Do R.K., Hatada E., Lee H., Tourigny M.R., Hilbert D., and Chen-Kiang S. Attenuation of apoptosis underlies B lymphocyte stimulator enhancement of humoral immune response. J. Exp. Med. 192 (2000) 953-964
4. Batten M., Groom J., Cachero T.G., Qian F., Schneider P., Tschopp J., Browning J.L., and Mackay F. BAFF mediates survival of peripheral immature B lymphocytes. J. Exp. Med. 192 (2000) 1453-1466
5. Varfolomeev E., Kischkel F., Martin F., Seshasayee D., Wang H., Lawrence D., Olsson C., Tom L., Erickson S., French D., Schow P., Grewal I.S., and Ashkenazi A. APRIL-deficient mice have normal immune system development. Mol. Cell. Biol. 24 (2004) 997-1006
6. Schneider P., MacKay F., Steiner V., Hofmann K., Bodmer J.L., Holler N., Ambrose C., Lawton P., Bixler S., Acha-Orbea H., Valmori D., Romero P., Werner-Favre C., Zubler R.H., Browning J.L., and Tschopp J. BAFF, a novel ligand of the tumor necrosis factor family, stimulates B-cell growth. J. Exp. Med. 189 (1999) 1747-1756
7. López-Fraga M., Fernández R., Albar J.P., and Hahne M. Biologically active APRIL is secreted following intracellular processing in the Golgi apparatus by furin convertase. EMBO Rep. 2 (2001) 945-951
8. Marsters S.A., Sheridan J.P., Pitti R.M., Brush J., Goddard A., and Ashkenazi A. Identification of a ligand for the death-domain-containing receptor Apo3. Curr. Biol. 23 (1998) 525-528
9. Pradet-Balade B., Medema J.P., López-Fraga M., Lozano J.C., Kolfschoten G.M., Picard A., Martínez-A C., Garcia-Sanz J.A., and Hahne M. An endogenous hybrid mRNA encodes TWE-PRIL, a functional cell surface TWEAK-APRIL fusion protein. EMBO J. 21 (2002) 5711-5720
10. Gross J.A., Johnston J., Mudri S., Enselman R., Dillon S.R., Madden K., Xu W., Parrish-Novak J., Foster D., Lofton-Day C., Moore M., Littau A., Grossman A., Haugen H., Foley K., Blumberg H., Harrison K., Kindsvogel W., and Clegg C.H. TACI and BCMA are receptors for a TNF homologue implicated in B-cell autoimmune disease. Nature 27 (2000) 404 995
11. Groom J., Kalled S.L., Cutler A.H., Olson C., Woodcock S.A., Schneider P., Tschopp J., Cachero T.G., Batten M., Wheway J., Mauri D., Cavill D., Gordon T.P., Mackay C.R., and Mackay F. Association of BAFF/BLyS over expression and altered B cell differentiation with Sjögren's syndrome. J. Clin. Invest. 109 (2002) 109 59
12. Cheema G.S., Roschke V., Hilbert D.M., and Stohl W. Elevated serum B lymphocyte stimulator levels in patients with systemic immune-based rheumatic diseases. Arthritis Rheum. 44 (2001) 1313-1319
13. Zhang J., Roschke V., Baker K.P., Wang Z., Alarcón G.S., Fessler B.J., Bastian H., Kimberly R.P., and Zhou T. Cutting edge: a role for B lymphocyte stimulator in systemic lupus erythematosus. J. Immunol. 166 (2001) 6-10
14. Yu G., Boone T., Delaney J., Hawkins N., Kelley M., Ramakrishnan M., McCabe S., Qiu W.R., Kornuc M., Xia X.Z., Guo J., Stolina M., Boyle W.J., Sarosi I., Hsu H., Senaldi G., and Theill L.E. APRIL and TALL-1 and receptors BCMA and TACI: system for regulating humoral immunity. Nat. Immunol. 1 (2000) 252-256
15. Wu Y., Bressette D., Carrell J.A., Kaufman T., Feng P., Taylor K., Gan Y., Cho Y.H., Garcia A.D., Gollatz E., Dimke D., LaFleur D., Migone T.S., Nardelli B., Wei P., Ruben S.M., Ullrich S.J., Olsen H.S., Kanakaraj P., Moore P.A., and Baker K.P. Tumor necrosis factor (TNF) receptor superfamily member TACI is a high affinity receptor for TNF family members APRIL and BLyS. J. Biol. Chem. 275 (2000) 35478-35485
16. Rennert P., Schneider P., Cachero T.G., Thompson J., Trabach L., Hertig S., Holler N., Qian F., Mullen C., Strauch K., Browning J.L., Ambrose C., and Tschopp J. A soluble form of B cell maturation antigen, a receptor for the tumor necrosis factor family member APRIL, inhibits tumor cell growth. J. Exp. Med. 192 (2000) 1677-1683
17. Thompson J.S., Bixler S.A., Qian F., Vora K., Scott M.L., Cachero T.G., Hession C., Schneider P., Sizing I.D., Mullen C., Strauch K., Zafari M., Benjamin C.D., Tschopp J., Browning J.L., and Ambrose C. BAFFR, a novel TNF receptor that specifically interacts with BAFF. Science 16 (2001) 2108-2111
18. Yan M., Brady J.R., Chan B., Lee W.P., Hsu B., Harless S., Cancro M., Grewal I.S., and Dixit V.M. Identification of a novel receptor for B lymphocyte stimulator that is mutated in a mouse strain with severe B cell deficiency. Curr. Biol. 11 (2001) 1547-1552
19. Stein J.V., López-Fraga M., Elustondo F.A., Carvalho-Pinto C.E., Rodríguez D., Gómez-Caro R., De Jong J., Martínez-A C., Medema J.P., and Hahne M. APRIL modulates B and T cell immunity. J. Clin. Invest. 109 (2002) 1587-1598
20. Litinskiy M.B., Nardelli B., Hilbert D.M., He B., Schaffer A., Casali P., and Cerutti A. DCs induce CD40-independent immunoglobulin class switching through BlyS and APRIL. Nat. Immunol. 3 (2002) 822-829
21. Avery D.T., Kalled S.L., Ellyard J.I., Ambrose C., Bixler S.A., Thien M., Brink R., Mackay F., Hodgkin P.D., and Tangye S.G. BAFF selectively enhances the survival of plasma blasts generated from human memory B cells. J. Clin. Invest. 12 (2003) 286-297
22. Tan E.M., Cohen A.S., Fries J.F., Masi A.T., McShane D.J., Rothfield N.F., Schaller J.G., Talal N., and Winchester R.J. The 1982 revised criteria for the classification of systemic lupus erythematosus. Arthritis Rheum. 25 (1982) 1271
23. Arnett F.C., Edworthy S.M., Bloch D.A., et al. The American Rheumatism Association 1987 revised criteria for the classification of rheumatoid arthritis. Arthritis Rheum. (1988) 315-324
24. Morel J., Roubille C., Planelles L., Rocha C., Fernandez L., Lukas C., Hahne M., and Combe B. Serum levels of tumour necrosis factor family members a proliferation-inducing ligand (APRIL) and B lymphocyte stimulator (BLyS) are inversely correlated in systemic lupus erythematosus. Ann. Rheum. Dis. 68 (2009) 997-1002
25. Koyama T., Tsukamoto H., Miyagi Y., Himeji D., Otsuka J., Miyagawa H., Harada M., and Horiuchi T. Raised serum APRIL levels in patients with systemic lupus erythematosus. Ann. Rheum. Dis. 64 (2005) 1065-1067
26. George-Chandy A., Trysberg E., and Eriksson K. Raised intrathecal levels of APRIL and BAFF in patients with systemic lupus erythematosus: relationship to neuropsychiatric symptoms. Arthritis Res. Ther. 10 (2008) R97
27. Mackay F., Schneider P., Rennert P., and Browning J. BAFF and APRIL: a tutorial on B cell survival. Annu. Rev. Immunol. 21 (2003) 231-264
28. Ingold K., Zumsteg A., Tardivel A., Huard B., Steiner Q.G., Cachero T.G., Qiang F., Gorelik L., Kalled S.L., Acha-Orbea H., Rennert P.D., Tschopp J., and Schneider P. Identification of proteoglycans as the APRIL-specific binding partners. J. Exp. Med. 201 (2005) 1375-1383
29. Ng L.G., Mackay C.R., and Mackay F. The BAFF/APRIL system: life beyond B lymphocytes. Mol. Immunol. 42 (2005) 763-772
30. Roschke V., Sosnovtseva S., Ward C.D., Hong J.S., Smith R., Albert V., Stohl W., Baker K.P., Ullrich S., Nardelli B., Hilbert D.M., and Migone T.S. BLyS and APRIL form biologically active heterotrimers that are expressed in patients with systemic immune-based rheumatic diseases. J. Immunol. 169 (2002) 4314-4321
31. Kayagaki N., Yan M., Seshasayee D., Wang H., Lee W., French D.M., et al. BAFF/BLyS receptor 3 binds the B cell survival factor BAFF ligand through a discrete surface loop and promotes processing of NF-kB2. Immunity 17 (2002) 10 515-24
32. Claudio E., Brown K., Park S., Wang H., and Siebenlist U. BAFF-induced NEMO-independent processing of NK-kB2 in maturing B cells. Nat. Immunol. 3 (2002) 958-965
33. Khare S.D., Sarosi I., Xia X.Z., McCabe S., Miner K., Solovyev I., Hawkins N., Kelley M., Chang D., Van G., Ross L., Delaney J., Wang L., Lacey D., Boyle W.J., and Hsu H. Severe B cell hyperplasia and autoimmune disease in TALL-1 transgenic mice. Proc. Natl. Acad. Sci. U. S. A. (2000) 3370-3375
34. Baker K.P., Edwards B.M., Main S.H., Choi G.H., Wager R.E., Halpern W.G., Lappin P.B., Riccobene T., Abramian D., Sekut L., Sturm B., Poortman C., Minter R.R., Dobson C.L., Williams E., Carmen S., Smith R., Roschke V., Hilbert D.M., Vaughan T.J., and Albert V.R. Generation and characterization of LymphoStat-B, a human monoclonal antibody that antagonizes the bioactivities of B lymphocyte stimulator. Arthritis Rheum. 48 (2003) 3253-3265
35. Furie R., Stohl W., Ginzler E., Becker M., Mishra N., Chatham W., et al. Safety, pharmacokinetic and pharmacodynamic results of a phase 1 single and double dose-escalation study of Lymphostat-B (human monoclonal antibody to BLyS) in SLE patients [abstract]. Arthritis Rheum. 48 (2003) S377 (suppl)
36. Cancro M.P. Peripheral B-cell maturation: the intersection of selection and homeostasis. Immunol. Rev. 197 (2004) 89-101
37. Medema J.P., Planelles-Carazo L., Hardenberg G., and Hahne M. The uncertain glory of APRIL. Cell Death Differ. 10 (2003) 1121-1125
38. McHale J.C., McKie A.B., Tarttelin E.E., and Inglehearn C.F. Expression map of human chromosome region 17p13.3, spanning the RP13 dominant retinitis pigmentosa locus, the Miller-Dieker lissencephaly syndrome (MDLS) region, and a putative tumour suppressor locus. Cytogenet. Cell Genet. 88 (2000) 225-229
39. Nath S.K., Kelly J.A., Namjou B., Lam T., Bruner G.R., Scofield R.H., Aston C.E., and Harley J.B. Evidence for a susceptibility gene, SLEV1, on chromosome 17p13 in families with vitiligo-related systemic lupus erythematosus. Am. J. Hum. Genet. 69 (2001) 1401-1406
40. Spritz R.A., Gowan K., Bennett D.C., and Fain P.R. Novel vitiligo susceptibility loci on chromosomes 7 (AIS2) and 8 (AIS3), confirmation of SLEV1 on chromosome 17, and their roles in an autoimmune diathesis. Am. J. Hum. Genet. (2004) 188-191
41. Seyler T.M., Park Y.W., Takemura S., Bram R.J., Kurtin P.J., Goronzy J.J., and Weyand C.M. BLyS and APRIL in rheumatoid arthritis. J. Clin. Invest. 115 (2005) 3083-3092
42. Tan S.M., Xu D., Roschke V., Perry J.W., Arkfeld D.G., Ehresmann G.R., Migone T.S., Hilbert D.M., and Stohl W. Local production of B lymphocyte stimulator protein and APRIL in arthritic joints of patients with inflammatory arthritis. Arthritis Rheum. 48 (2003) 982-992
43. Vallerskog T., Heimbürger M., Gunnarsson I., Zhou W., Wahren-Herlenius M., Trollmo C., and Malmström V. Differential effects on BAFF and APRIL levels in rituximab-treated patients with systemic lupus erythematosus and rheumatoid arthritis. Arthritis Res. Ther. 8 6 (2006) R167